Status report
Get it in writing
The official USPTO status record for XCELLDERMA, serial 99532907, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
XCELLDERMASerial 99532907 · Principal Register
Pending · Under Examination
Owner: Regenerex Pharma, Inc.
Class 005 - Pharmaceuticals
Filed Dec 05, 2025
The record shows that the mark “XCELLDERMA” is currently pending on the Principal Register, owned by Regenerex Pharma, Inc., a Nevada corporation. The application was filed on December 5, 2025 and the most recent status update, a non‑final Office action, was issued on April 21, 2026. The mark covers pharmaceutical preparations for wound care, including wound dressings and healing preparations, as listed in class 005. A similar name used in the same or closely related medical or pharmaceutical context would raise the closest concern. The record does not give the mark control over every use of the wording; it is limited to the goods and services described. No enforcement activity—oppositions, cancellations, or court actions—is visible in the supplied history. The next consequential date would be the response deadline to the Office action, but that date is not provided. For someone considering a similar name, the pending status and specific wound‑care focus suggest a meaningful risk of conflict in that area.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.